American International Group, Inc. Passage Bio, Inc. Transaction History

American International Group, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.63 - $3.46 $30,014 - $63,712	-18,414 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$2.66 - $6.49 $3,444 - $8,404	-1,295 Reduced 6.57%	18,414 $57,000
Q4 2021 Feb 11, 2022	SELL	$6.24 - $10.2 $3,681 - $6,018	-590 Reduced 2.91%	19,709 $125,000
Q3 2021 Nov 12, 2021	SELL	$9.73 - $15.52 $4,689 - $7,480	-482 Reduced 2.32%	20,299 $202,000
Q2 2021 Aug 13, 2021	BUY	$12.44 - $19.45 $50,021 - $78,208	4,021 Added 23.99%	20,781 $275,000
Q1 2021 May 07, 2021	BUY	$16.24 - $29.83 $37,238 - $68,400	2,293 Added 15.85%	16,760 $293,000
Q4 2020 Feb 12, 2021	BUY	$14.28 - $29.73 $90,606 - $188,636	6,345 Added 78.12%	14,467 $370,000
Q3 2020 Nov 04, 2020	SELL	$12.39 - $26.15 $2,292 - $4,837	-185 Reduced 2.23%	8,122 $107,000
Q2 2020 Aug 12, 2020	BUY	$14.59 - $36.07 $121,199 - $299,633	8,307 New	8,307 $227,000

38.7M

7.7K

Ticker PASG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,463,200
Market Cap $35.9M
Description
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.